Choline Supplementation for Cannabis Use During Pregnancy
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if the nutritional supplement phosphatidylcholine (a form of choline) can enhance brain development in babies whose mothers used cannabis during pregnancy. Pregnant participants will receive either the supplement or a placebo from about 16 weeks into their pregnancy until birth. Researchers will assess the baby's brain response to sounds at 4 weeks old and their behavior at 3 months old. The study seeks pregnant women who have used cannabis products during their current pregnancy. As a Phase 1 trial, the research focuses on understanding how the treatment works in people, offering participants the chance to be among the first to receive this potentially beneficial supplement.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
Is there any evidence suggesting that this treatment is likely to be safe for humans?
Research shows that choline, tested as phosphatidylcholine in this trial, is safe for use during pregnancy. Previous studies have found that higher choline levels in pregnant women link to better attention and brain development in their children. This suggests that choline might support healthy brain development without causing serious side effects.
Researchers are also examining choline's potential to reduce pregnancy risks, such as issues with brain and nerve development in babies. Studies indicate that low choline intake in pregnant women can increase the risk of neural tube defects, which affect the baby's brain and spine. Therefore, adequate choline intake is important.
Overall, the treatment appears well-tolerated, with no major safety concerns reported. However, as this trial is still in its early stages, researchers continue to gather more information about its safety and effectiveness.12345Why do researchers think this study treatment might be promising?
Researchers are excited about choline supplementation during pregnancy for cannabis users because it offers a natural approach that directly supports brain development in the fetus. Unlike other treatments that might focus on reducing cannabis dependency, choline specifically targets the potential cognitive impacts on the developing baby by providing an essential nutrient for brain health. This approach is unique because it leverages phosphatidylcholine, a form of choline, to potentially mitigate cognitive risks without relying on pharmaceutical interventions.
What evidence suggests that choline supplementation could be effective for improving brain development in infants exposed to cannabis during pregnancy?
Research has shown that higher levels of choline in pregnant women might lessen cannabis's impact on a baby's brain development. One study found that taking choline supplements during pregnancy led to better thinking skills in children. Another study suggested a link between choline and improved brain growth and mental function in children. In this trial, participants will receive either a phosphatidylcholine supplement or a placebo to evaluate choline's potential benefits for supporting healthier brain development if cannabis is used during pregnancy. Overall, choline appears to offer potential benefits for newborns' brain development.23467
Who Is on the Research Team?
M. Camille Hoffman, MD
Principal Investigator
University of Colorado, Denver
Sharon Hunter, PhD
Principal Investigator
University of Colorado School of Medicine
Are You a Good Fit for This Trial?
This trial is for pregnant women who have used cannabis during their current pregnancy. It aims to see if a nutritional supplement, phosphatidylcholine, can improve their baby's brain development in the first 18 months after birth.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either phosphatidylcholine or placebo from approximately 16 weeks gestation through birth
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Choline
Choline is already approved in United States, European Union, Canada for the following indications:
- Dietary supplement
- Dietary supplement
- Dietary supplement
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor